News

March 31, 2017

Risk Assessment Tool Helps UK GPs Diagnose Serious Bowel Conditions in Younger Patients

News

A new research-based risk assessment tool will help general practitioners identify symptoms of bowel cancer and inflammatory bowel disease (IBD) in patients under 50 years of age. The assessment tool ... Read more

March 30, 2017March 30, 2017

Crohn’s Disease Research in Asia Supported by $5.2M Helmsley Trust Grants

News

The Chinese University of Hong Kong (CUHK) and the Australasian Gastro Intestinal Research Foundation (AGIRF) were awarded $5.2 million in grants from the Leona M. and Harry B. Helmsley Charitable ... Read more

March 29, 2017March 29, 2017

Portuguese Blueberry Shows Potent Anti-Inflammatory Effect in Colitis Animal Model

News

An active ingredient of a specific type of Portuguese blueberry shows increased anti-inflammatory effects in the intestines of an animal model with colitis when compared to mesalamine (5-ASA), a common ... Read more

March 28, 2017March 28, 2017

Neurological Symptoms of Gulf War Illness Linked to Intestinal Disturbances, Study Suggests

News

Gulf War Illness (GWI) has many symptoms, and now a link between changes in the gut microbiome (bacteria living in the intestines) and neuroinflammation (inflammation of the brain) has been identified, ... Read more

March 27, 2017

European Union Approves Amgevita for Crohn’s Disease and Ulcerative Colitis

News

The European Union has approved Amgen‘s Amgevita, a biosimilar to Humira (adalimumab), as a treatment for inflammatory bowel diseases (IBDs) such as Crohn’s and ulcerative colitis. The European Commission decision applies ... Read more

March 24, 2017March 24, 2017

Review: Biologics Help Maintain Intestinal Mucosa Health in Crohn’s, Ulcerative Colitis Patients

News

Specific biologic treatments don’t only relieve symptoms but can also maintain intestinal health in patients with inflammatory bowel disease (IBD), according to a review that analyzed medicines approved by the U.S. Food ... Read more

March 23, 2017March 23, 2017

Positive Interim Trial Results of Brilacidin for IBD Announced by Cellceutix

News

Cellceutix announced additional interim positive findings from its ongoing Phase 2a trial evaluating brilacidin (PMX-30063) as a treatment for two types of inflammatory bowel disease (IBD) – ulcerative proctitis and ulcerative proctosigmoiditis (UP/UPS). ... Read more

March 22, 2017March 22, 2017

First Patient Dosed in Extension Trial of RHB-104 as Crohn’s Therapy

News

The first patient has been dosed in MAP US2, an open-label extension clinical trial evaluating RHB-104 as a treatment for Crohn’s disease, according to its maker, RedHill Biopharma. MAP US is ... Read more

March 21, 2017March 21, 2017

Arizona State, Mayo Clinic Researchers Identify Potential New Biomarkers for Diagnosing Crohn’s

News

Researchers have identified novel biomarkers for diagnosing Crohn’s disease in a collaborative study between Arizona State University’s Biodesign Institute and the Mayo Clinic. They also built a novel blood test that distinguishes ... Read more

March 20, 2017March 20, 2017

Digital Illustration of Crohn’s Disease Wins Wellcome Image Awards 2017

News

Spooky Pooka, a professional illustrator and artist who works with computer-generated imagery technology, is the overall winner of the Wellcome Image Awards 2017 for his representation of the physical and emotional ... Read more